Etodolac



Etodolac





(ee toe doe’ lak)

PREGNANCY CATEGORY C


Drug Classes

Analgesic (nonopioid)

NSAID


Therapeutic Actions

Inhibits prostaglandin synthesis by inhibiting the enzyme, cyclo-oxygenase.


Indications



  • Acute or long-term use in the management of signs and symptoms of osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis


  • Management of pain



Available Forms

Capsules—200, 300 mg; tablets—400, 500 mg; ER tablets—400, 500, 600 mg


Dosages

Adults



  • Osteoarthritis, rheumatoid arthritis: Initially, 600–1,000 mg/day PO in divided doses; maintenance ranges, 600–1,200 mg/day in divided doses. Do not exceed 1,200 mg/day. Patients less than 60 kg: Do not exceed 20 mg/kg. ER: 400–1,000 mg/day PO; adjust based on patient response. Do not exceed 1,200 mg/day.


  • Analgesia, acute pain: 200–400 mg every 6–8 hr PO. Do not exceed 1,200 mg/day.

Patients 6–16 yr

Jul 20, 2016 | Posted by in NURSING | Comments Off on Etodolac

Full access? Get Clinical Tree

Get Clinical Tree app for offline access